Sector dividends Dr. Lal PathLabs Limited

Equities

Delayed NSE India S.E. Other stock markets 08:56:50 08/06/2026 BST			5-day change	1st Jan Change
1,543.90 ^INR	+0.46%		-2.01%	+4.25%

05-04	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy	MT
04-30	Dr. Lal PathLabs Limited completed the acquisition of Shahbazkers Diagnostic Centre Private Limited.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (N)	Dividend Yield (N+1)	P/E (N)	Price to Book (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Capi.($)
DR. LAL PATHLABS LIMITED	0.91%	1.17%	50.66x	10.44x	8.92x	31.31x	39.64x	2.7B
NATERA, INC.	-.--%	-.--%	-130.15x	16.5x	10.65x	-149.96x	-118.7x	30.84B
LABCORP HOLDINGS INC.	1.1%	1.11%	19.04x	2.31x	1.79x	10.32x	12.45x	21.74B
SONIC HEALTHCARE LIMITED	5.57%	5.68%	15.81x	1.09x	1.25x	7.07x	12.9x	6.76B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	1.64%	2.14%	32.91x	1.6x	1.43x	11.62x	19.82x	1.64B
FLEURY S.A.	7.6%	8.19%	11.66x	1.58x	1.24x	4.86x	8.32x	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	0.96%	1.14%	26.38x	1.57x	1.07x	8.8x	12.44x	1.52B
VIJAYA DIAGNOSTIC CENTRE LIMITED	0.12%	0.12%	82.43x	14.81x	17.17x	42.38x	57.78x	1.48B
NEOGENOMICS, INC.	-.--%	-.--%	-24.46x	-	-	-	-	1.42B
H.U. GROUP HOLDINGS, INC.	3.72%	3.72%	28.17x	1.4x	0.84x	7.56x	35.61x	1.16B
METROPOLIS HEALTHCARE LIMITED	0.38%	0.45%	55.24x	7.61x	6.61x	27.26x	39.42x	1.16B
THYROCARE TECHNOLOGIES LIMITED	1.82%	2.09%	52.13x	-	-	-	-	862M
BML, INC.	3.35%	3.77%	18.26x	1.06x	-	-	-	837M
NOVOGENE CO., LTD.	0.37%	0.44%	26.19x	1.97x	-	-	-	807M
INTEGRAL DIAGNOSTICS LIMITED	3.93%	4.65%	28.31x	1.12x	1.32x	6.22x	10.98x	545M
Average	2.1%	2.31%	19.50x	4.85x	4.75x	0.68x	11.88x	5B
Weighted average by Cap.	1.22%	1.29%	-39.49x	8.76x	6.20x	-57.96x	-41.53x